Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Evolutionary Genomics's pretax income for the
three
months ended in Dec. 2022 was $-0.33 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2022 was $-1.94 Mil.
Evolutionary Genomics's pretax margin was %.
Evolutionary Genomics (OTCPK:FNAM) Pre-Tax Income Explanation
Evolutionary Genomics's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolutionary Genomics Pre-Tax Income Related Terms
Evolutionary Genomics Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Evolutionary Genomics's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FNAM vs BXRX, GNCA, XSNX: Pre-Tax Income Comparison
For the Biotechnology subindustry, Evolutionary Genomics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolutionary Genomics Pre-Tax Income vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Evolutionary Genomics's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolutionary Genomics (FNAM) has a Pre-Tax Income of $-1.94 Mil as of Dec. 2022. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Evolutionary Genomics and its competitors.
Is Evolutionary Genomics' Pre-Tax Income too high?
Evolutionary Genomics' current Pre-Tax Income is $-1.94 Mil. Overall, Evolutionary Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Evolutionary Genomics' Pre-Tax Income compare to BXRX and GNCA?
Evolutionary Genomics' Pre-Tax Income of $-1.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Evolutionary Genomics and its competitors. Evolutionary Genomics's current Pre-Tax Income is $-1.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolutionary Genomics stock overvalued right now?
Evolutionary Genomics (FNAM) has a current Pre-Tax Income of $-1.94 Mil. The current Pre-Tax Income is $-1.94 Mil. Evolutionary Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Evolutionary Genomics (FNAM), the current Pre-Tax Income is $-1.94 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
31GF Score
Get the complete analysis for FNAM
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FNAM has been successfully added to your 
